Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Altmann

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry|February 11, 2023
The most common linkers in bioactive molecules and their bioisosteric replacement networkPeter Ertl, Eva Altmann, Sophie Racine
Mini Reviews in Medicinal Chemistry|October 9, 2002
N(7)-substituted-5-aryl-pyrrolo[2,3-d]pyrimidines represent a versatile class of potent inhibitors of the tyrosine kinase c-SrcEva Altmann, Leo Widler, Martin Missbach
European Journal of Medicinal Chemistry|September 24, 2025
Ring systems in medicinal chemistry: A cheminformatics analysis of ring popularity in drug discovery over timePeter Ertl, Eva Altmann, Rainer Wilcken
Journal of Medicinal Chemistry|July 15, 2020
The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over TimePeter Ertl, Eva Altmann, Jeffrey M McKenna
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituentsEva Altmann, Jonathan Green, Marina Tintelnot-Blomley
European Journal of Medicinal Chemistry|May 31, 2022
Ring replacement recommender: Ring modifications for improving biological activityPeter Ertl, Eva Altmann, Sophie Racine, et al.
Journal of Medicinal Chemistry|November 13, 2004
Novel purine nitrile derived inhibitors of the cysteine protease cathepsin KEva Altmann, Sandra W Cowan-Jacob, Martin Missbach
Bioorganic & Medicinal Chemistry|July 8, 2023
Which boronic acids are used most frequently for synthesis of bioactive molecules?Peter Ertl, Eva Altmann, Sophie Racine, et al.
Journal of Medicinal Chemistry|May 31, 2002
Arylaminoethyl amides as novel non-covalent cathepsin K inhibitorsEva Altmann, Johanne Renaud, Jonathan Green, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Complementary use of ion trap/time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in ratWolfgang Blum, Thomas Buhl, Eva Altmann, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|February 11, 2023
The most common linkers in bioactive molecules and their bioisosteric replacement networkPeter Ertl, Eva Altmann, Sophie Racine
Mini Reviews in Medicinal Chemistry|October 9, 2002
N(7)-substituted-5-aryl-pyrrolo[2,3-d]pyrimidines represent a versatile class of potent inhibitors of the tyrosine kinase c-SrcEva Altmann, Leo Widler, Martin Missbach
European Journal of Medicinal Chemistry|September 24, 2025
Ring systems in medicinal chemistry: A cheminformatics analysis of ring popularity in drug discovery over timePeter Ertl, Eva Altmann, Rainer Wilcken
Journal of Medicinal Chemistry|July 15, 2020
The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over TimePeter Ertl, Eva Altmann, Jeffrey M McKenna
Bioorganic & Medicinal Chemistry Letters|June 5, 2003
Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituentsEva Altmann, Jonathan Green, Marina Tintelnot-Blomley
European Journal of Medicinal Chemistry|May 31, 2022
Ring replacement recommender: Ring modifications for improving biological activityPeter Ertl, Eva Altmann, Sophie Racine, et al.
Journal of Medicinal Chemistry|November 13, 2004
Novel purine nitrile derived inhibitors of the cysteine protease cathepsin KEva Altmann, Sandra W Cowan-Jacob, Martin Missbach
Bioorganic & Medicinal Chemistry|July 8, 2023
Which boronic acids are used most frequently for synthesis of bioactive molecules?Peter Ertl, Eva Altmann, Sophie Racine, et al.
Journal of Medicinal Chemistry|May 31, 2002
Arylaminoethyl amides as novel non-covalent cathepsin K inhibitorsEva Altmann, Johanne Renaud, Jonathan Green, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 26, 2003
Complementary use of ion trap/time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in ratWolfgang Blum, Thomas Buhl, Eva Altmann, et al.
Pageof 3